06/04/2026
🎗️When Rollo, an otherwise healthy 8-year-old boxer, was rushed to urgent care late one night; his condition was critical. He was struggling to breathe, with pale gums and cold extremities. Diagnostic imaging revealed splenic tumors which are often associated with hemangiosarcoma and a historically poor prognosis🎗️
Building on earlier research, including the Canine Hemangiosarcoma Molecular Profiling study, 🎗️Ethos Discovery🎗️is advancing a coordinated precision-medicine research program focused on hemangiosarcoma. Current and planned studies include ETHOS-PUSH, therapeutic trials, and the Canine Hemangiosarcoma Precision Medicine and Liquid Biopsy Program (CHAMP). These efforts aim to refine diagnostic accuracy, improve prognostic insight, and explore more targeted treatment strategies.
For veterinary professionals at Ethos, this work is not separate from clinical practice. Across their network of 140 emergency and specialty hospitals, clinicians partner directly with Ethos Discovery to identify unmet needs, contribute to research, and help translate new knowledge back into patient care.
Rollo’s remission reflects more than a positive outcome for one dog and his family. It represents the kind of meaningful work that happens when veterinary professionals are empowered to care for patients while also helping shape the future of medicine.